Chylous ascites is a rare form of ascites characterized by accumulation of lymphatic fluid (chyle) in the peritoneal cavity. Chyle is a milky-white lymphatic fluid carrying long-chain fatty acids absorbed from the small intestine in the form of chylomicrons. The most common etiologies include lymphoma, surgical complications (especially retroperitoneal/abdominal surgery), trauma, and cirrhosis. In developed countries, malignancy (especially lymphoma) is the most common cause, while in developing countries, tuberculosis and filariasis are more prevalent. Damage or obstruction of the cisterna chyli or thoracic duct is the main mechanism. Diagnosis is established by triglyceride levels >200 mg/dL (>2.26 mmol/L) in fluid obtained by paracentesis. On imaging, it may show certain characteristic findings not seen in simple ascites; however, definitive diagnosis relies on biochemical analysis.
Age Range
20-75
Peak Age
50
Gender
Equal
Prevalence
Uncommon
Chylous ascites develops when chyle leaks into the peritoneal cavity due to disruption of the lymphatic system integrity. Three main mechanisms have been described: (1) Direct damage to the cisterna chyli or major lymphatic channels — following surgery, trauma, or radiation; (2) Lymphatic obstruction — due to malignancy (lymphoma most common), metastatic lymph node involvement, tuberculosis, or retroperitoneal fibrosis, leading to proximal pressure increase and leakage from megalymphatic vessels; (3) Increased lymphatic wall permeability — due to congenital lymphatic malformations or impaired lymphatic wall integrity in inflammatory processes. The high triglyceride and chylomicron content of chyle may produce different density/signal characteristics compared to simple ascites on imaging: slightly higher fluid density on CT (-10 to +20 HU range), mildly hyperintense T1 signal on MRI (due to fat content), and signal loss on fat-suppressed sequences are typical findings.
Gravity-dependent fat-water phase separation in peritoneal fluid with low-density fat layer anteriorly and high-density serous layer posteriorly is considered pathognomonic for chylous ascites. Although rarely seen, it supports the diagnosis with high confidence when present.
On CT, chylous ascitic fluid demonstrates slightly different density values compared to simple ascites. While simple (transudative) ascites is typically 0-10 HU, chylous ascites may show heterogeneous density ranging from -10 to +20 HU. Due to the fat-water mixture, near-fat density negative values in some areas and positive values due to protein content in other areas may be observed.
Report Sentence
Fluid collection in the peritoneal cavity demonstrating different density values from simple ascites (average ___ HU); paracentesis and biochemical analysis recommended for chylous ascites evaluation.
A rare but pathognomonic finding, fat-fluid level is seen when fat content accumulates at the fluid surface due to gravity. On CT in supine position, a low-density fat layer anteriorly and a higher-density serous layer posteriorly are observed. This finding becomes more prominent at high triglyceride levels (>500 mg/dL).
Report Sentence
Fat-fluid level with low-density fluid anteriorly and higher-density fluid posteriorly, consistent with chylous ascites.
On T1-weighted MRI, chylous ascites demonstrates mild-to-moderate hyperintense signal compared to simple ascites. This increased T1 signal intensity is due to the short T1 relaxation time of lipid molecules in chylomicrons. Signal intensity is between subcutaneous fat and muscle.
Report Sentence
Peritoneal fluid collection demonstrates mildly hyperintense signal on T1-weighted MRI compared to simple ascites, consistent with chylous ascites.
Signal loss or decrease in the ascitic fluid is observed on fat-suppressed MRI sequences (STIR, fat-sat T1, Dixon fat map). This finding is direct evidence of lipid content and is not seen in simple ascites. On Dixon fat-water separation, chylous ascites may show signal on both water and fat maps.
Report Sentence
Signal loss in peritoneal fluid on fat-suppressed MRI sequences supports lipid content, consistent with chylous ascites.
On US, chylous ascites may demonstrate diffuse fine echogenic particles or mildly increased echogenicity compared to simple (anechoic) ascites. The fluid may take a 'cloudy' or 'haze-like' appearance rather than being completely anechoic. Fat droplets and chylomicrons may be visualized as small echogenic particles.
Report Sentence
Peritoneal fluid on US demonstrates increased echogenicity and fine echogenic particles compared to simple ascites; chylous ascites should be considered.
Lymphoscintigraphy is a valuable nuclear medicine method for demonstrating the lymphatic leak source. After intradermal injection of 99mTc-filtered sulfur colloid into the feet, activity is traced along lymphatic channels. Abnormal accumulation in the peritoneal cavity confirms lymphatic leak.
Report Sentence
Abnormal radionuclide accumulation in peritoneal cavity on lymphoscintigraphy, consistent with lymphatic leak and chylous ascites.
Criteria
Chylous ascites developing in the setting of lymphoma (most common), metastatic tumor, or primary peritoneal malignancy. Accompanied by retroperitoneal lymphadenopathy and lymphatic obstruction findings.
Distinct Features
Most common cause in developed countries. Lymphoma 50-70%. Progressive course, treatment of underlying malignancy may also control chylous ascites.
Criteria
Chylous ascites developing 2-10 days after abdominal/retroperitoneal surgery or trauma. Occurs through damage to cisterna chyli or major lymphatic channels.
Distinct Features
Generally self-limited, 50-80% spontaneous resolution with conservative treatment. MCT diet, TPN, somatostatin analogs. Lymphangiography + embolization or surgery in refractory cases.
Criteria
Chylous ascites due to lymphatic obstruction from tuberculosis or filariasis. Common in developing countries.
Distinct Features
TB: resolution with anti-TB treatment, rim-enhancing LAP. Filariasis: microfilariae, diethylcarbamazine. Endemic area history critical.
Distinguishing Feature
Peritoneal carcinomatosis shows complex ascites with peritoneal nodules/implants and omental cake; fat suppression signal loss not expected. Chylous ascites lacks peritoneal nodules and T1 hyperintensity + fat suppression signal loss are typical.
Distinguishing Feature
Hemorrhagic ascites shows high density on CT (30-70 HU); chylous ascites lower density (-10 to +20 HU). On MRI, hemorrhagic ascites does not show signal loss on fat suppression, chylous ascites does.
Distinguishing Feature
Infected ascites shows peritoneal thickening/enhancement; fat suppression signal loss not expected. Clinically accompanied by fever and leukocytosis; chylous ascites is generally afebrile.
Distinguishing Feature
Pseudomyxoma peritonei characterized by gelatinous ascites and mucinous implants with organ surface scalloping. Chylous ascites lacks scalloping and mucinous implants; fat suppression signal loss not expected in pseudomyxoma.
Urgency
urgentManagement
medicalBiopsy
Not NeededFollow-up
specialist-referralTreatment is determined by the underlying etiology. First step is confirming triglyceride levels by diagnostic paracentesis. In malignancy-related cases, treatment of primary disease is essential. In postoperative/traumatic cases, conservative approach: MCT diet, TPN, somatostatin analogs (octreotide). Lymphangiography + embolization or surgical ligation in refractory cases. Nutritional losses should be monitored.
Chylous ascites requires investigation of the underlying cause. Lymphoma is the most common malignant cause. Post-surgical lymphatic injury is the most common iatrogenic cause. Treatment is directed at the underlying cause. Dietary modification (medium-chain triglycerides) and paracentesis provide symptomatic relief.